Cargando…
Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a viral respiratory illness initially described in Wuhan, China, and was declared a pandemic by World Health Organization (WHO) in 2020, and the disease is named coronavirus disease (COVID-19). SARS-CoV2 is known to cause fever, cou...
Autores principales: | Madala, Samragnyi, Krzyzak, Michael, Dehghani, Shabnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978146/ https://www.ncbi.nlm.nih.gov/pubmed/33758713 http://dx.doi.org/10.7759/cureus.13425 |
Ejemplares similares
-
The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
por: Jindal, Vishal, et al.
Publicado: (2018) -
The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017) -
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
por: Patriarcheas, Vasileios, et al.
Publicado: (2020) -
Beware of Warfarin-Induced Skin Necrosis in the Setting of Heparin-Induced Thrombocytopenia
por: Dhawan, Natasha
Publicado: (2020) -
Early Utilization of Intravenous Immunoglobulin in Heparin-Induced Thrombocytopenia for Limb Salvaging Purposes
por: Abu Kar, Sarah, et al.
Publicado: (2022)